Biopharmaceutical

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has awarded nearly $54 million in grants for 13 high-impact projects for research, development and testbeds for pandemic response. The funding, which was provided by the American Rescue Act, will support projects at eight manufacturing innovation institutes in the Manufacturing USA ® network, working with more 80 partners including leading research universities, nonprofits, and small and large manufacturers.

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has made two awards totaling $153 million to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The awards were announced today by U.S. Secretary of Commerce Gina Raimondo at the NIIMBL annual meeting in Washington, D.C.

Today, the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) announced a new competition for awards to support industry-driven consortia in developing technology roadmaps that will address high-priority research challenges to grow the advanced manufacturing sector in the U.S.

NIST’s Manufacturing USA Technology Roadmaps (MfgTech) program anticipates awarding up to eight awards with a period of performance of up to 18 months each, with individual awards of up to

Innovation and U.S. manufacturing are inextricably linked—that’s why the President launched the National Network for Manufacturing Innovation (NNMI), a network of manufacturing hubs across the country that is designed to sharpen America’s competitive edge in spurring the next generation of manufacturing jobs and investment. Each manufacturing hub brings together leaders from private companies, universities, and non-profits—alongside the Federal Government—to pioneer breakthroughs in emerging